BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, Ratings reports. The brokerage issued an outperform ...

The strategy is large with over $7 billion in assets. Many holdings overlap with those in small-growth sibling Janus Henderson Venture, which has over $3 billion in assets, and mid-growth Janus ...

Schommer has worked alongside Rao for much of his career, starting in 2007 as an analyst at Marsico Capital Management before moving to Janus in 2013, and then becoming comanager on this strategy ...

The Fund seeks long-term growth of capital. The Fund pursues its investment objective by normally investing in a portfolio of 30-40 common stocks selected for their growth potential. The Fund may ...

Signaling by type I cytokines involves the formation of receptor homodimers, heterodimers or higher order receptor oligomers. Here we report the cloning of a type I cytokine receptor subunit that ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Janus Corporation Ltd., incorporated in the year 1998, is a Small Cap company (having a market cap of Rs 12.21 Crore) operating in Miscellaneous sector. Janus Corporation Ltd. key Products/Revenue ...

Objective We aimed to understand the role of the transcriptional co-factor Yes-associated protein (Yap) in the molecular pathway underpinning the pathogenic transformation of synovial fibroblasts (SF) ...